Direkt zum Inhalt
Merck
  • Exercise training combined with antioxidant supplementation prevents the antiproliferative activity of their single treatment in prostate cancer through inhibition of redox adaptation.

Exercise training combined with antioxidant supplementation prevents the antiproliferative activity of their single treatment in prostate cancer through inhibition of redox adaptation.

Free radical biology & medicine (2014-09-23)
Jordan Gueritat, Luz Lefeuvre-Orfila, Sophie Vincent, Armel Cretual, Jean-Luc Ravanat, Arlette Gratas-Delamarche, Françoise Rannou-Bekono, Amélie Rebillard
ZUSAMMENFASSUNG

In preclinical models, exercise training (ET) or pomegranate juice (PJ) prevents prostate cancer progression. Here, we hypothesized that physical exercise combined with antioxidants could induce synergistic effects through oxidative stress modulation. Forty male Copenhagen rats with prostate tumors were divided into four groups: control, PJ, ET, and PJ+ET. Rats from the PJ group consumed 750 µl of PJ daily, rats from the ET group ran on a treadmill 5 days per week, and PJ+ET rats received the combined treatment. Each week, tumor growth was evaluated. After 4 weeks of treatment, the rats were euthanized and blood, muscles, and tumors were collected. Tumor Ki67, extracellular signal-regulated kinase (ERK) activation, Bcl-2 expression, and enzymatic and nonenzymatic antioxidant defenses, as well as oxidative stress markers (oxidized base, lipid peroxidation, protein carbonylation), were measured. PJ or ET significantly decreased prostate tumor proliferation (Ki67 staining, p<0.05) through the modulation of ERK phosphorylation, whereas the combination of treatments did not limit cancer progression. PJ significantly reduced Bcl-2 expression in tumors (p<0.05) and the combination of PJ and ET prevented this effect. PJ or ET increased enzymatic antioxidant defenses in muscle, PJ increased nonenzymatic antioxidant defenses in plasma and whole blood. In addition, PJ reduced TBARS and 8-oxodGuo levels in tumors as well as ET (p<0.05), whereas protein carbonyl levels were not affected by these two strategies. Paradoxically, association of PJ+ET did not increase antioxidant defenses and no reduction in oxidative stress markers was induced. Loading cancer cells with antioxidants blunts the positive effects of ET and interferes with important reactive oxygen species-mediated physiological processes such as antioxidant adaptations.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Heptan, suitable for HPLC, ≥99%
Sigma-Aldrich
Perchlorsäure, ACS reagent, 70%
Sigma-Aldrich
Heptan, ReagentPlus®, 99%
Sigma-Aldrich
Heptan, HPLC Plus, for HPLC, GC, and residue analysis, 99%
Sigma-Aldrich
Perchlorsäure, 70%, 99.999% trace metals basis
Sigma-Aldrich
Perchlorsäure, ACS reagent, 60%
Sigma-Aldrich
Fluorescein, for fluorescence, free acid
Sigma-Aldrich
2,4-Dinitrophenol, moistened with water, ≥98.0%
Sigma-Aldrich
Heptan, suitable for HPLC, ≥96%
Sigma-Aldrich
Heptan, anhydrous, 99%
Sigma-Aldrich
Phenolrot, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Phenolrot, ACS reagent
Supelco
Heptan, analytical standard
Supelco
Heptan, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
2,4-Dinitrophenol, PESTANAL®, analytical standard
Supelco
Perchlorsäure-Konzentrat, 0.01 M HClO4 in water (0.01N), eluent for IC
Fluorescein, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Heptan, biotech. grade, ≥99%